Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
JS Smolen, FC Breedveld, GR Burmester… - Annals of the …, 2016 - ard.bmj.com
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
Guidelines for musculoskeletal ultrasound in rheumatology
M Backhaus, GR Burmester, TH Gerber… - Annals of the …, 2001 - ard.bmj.com
Within the past decade, musculoskeletal ultrasound (US) has become an established
imaging technique for the diagnosis and follow up of patients with rheumatic diseases. 1–5 …
imaging technique for the diagnosis and follow up of patients with rheumatic diseases. 1–5 …
[HTML][HTML] Macrophages in rheumatoid arthritis
RW Kinne, R Bräuer, B Stuhlmüller… - Arthritis Research & …, 2000 - Springer
The abundance and activation of macrophages in the inflamed synovial membrane/pannus
significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be …
significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be …
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Abstract Objective The 1987 American College of Rheumatology (ACR; formerly, the
American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have …
American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
JS Smolen, RBM Landewé, JWJ Bijlsma… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …
SB Cohen, P Emery, MW Greenwald… - Arthritis & …, 2006 - Wiley Online Library
Objective To determine the efficacy and safety of treatment with rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
L Gossec, X Baraliakos, A Kerschbaumer… - Annals of the …, 2020 - ard.bmj.com
Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …
European S3-guidelines on the systemic treatment of psoriasis vulgaris
European S3-Guidelines on the systemic treatment of psoriasis vulgaris D Pathirana, AD
Ormerod, P Saiag, C Smith, PI Spuls, A Na Page 1 JEADV october 2009, volume 23 …
Ormerod, P Saiag, C Smith, PI Spuls, A Na Page 1 JEADV october 2009, volume 23 …
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors …
GR Burmester, R Blanco, C Charles-Schoeman… - The Lancet, 2013 - thelancet.com
Background Rheumatoid arthritis is a heterogeneous chronic disease, and no therapeutic
agent has been identified which is universally and persistently effective in all patients. We …
agent has been identified which is universally and persistently effective in all patients. We …
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis …
CE Antoni, A Kavanaugh, B Kirkham… - Arthritis & …, 2005 - Wiley Online Library
Objective To investigate the efficacy and tolerability of infliximab therapy for the articular and
dermatologic manifestations of active psoriatic arthritis (PsA). Methods One hundred four …
dermatologic manifestations of active psoriatic arthritis (PsA). Methods One hundred four …